Bank of America’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $147K | Buy |
31,297
+7,462
| +31% | +$35.1K | ﹤0.01% | 5364 |
|
|
2025
Q1 | $87K | Sell |
23,835
-7,827
| -25% | -$28.6K | ﹤0.01% | 5556 |
|
|
2024
Q4 | $149K | Buy |
31,662
+4,002
| +14% | +$18.9K | ﹤0.01% | 5365 |
|
|
2024
Q3 | $258K | Buy |
27,660
+753
| +3% | +$7.01K | ﹤0.01% | 5037 |
|
|
2024
Q2 | $155K | Buy |
26,907
+14,179
| +111% | +$81.5K | ﹤0.01% | 5214 |
|
|
2024
Q1 | $85.4K | Sell |
12,728
-16,345
| -56% | -$110K | ﹤0.01% | 5464 |
|
|
2023
Q4 | $188K | Buy |
29,073
+15,375
| +112% | +$99.2K | ﹤0.01% | 5195 |
|
|
2023
Q3 | $68.5K | Buy |
13,698
+6,175
| +82% | +$30.9K | ﹤0.01% | 5510 |
|
|
2023
Q2 | $53K | Sell |
7,523
-887
| -11% | -$6.24K | ﹤0.01% | 5585 |
|
|
2023
Q1 | $52.1K | Sell |
8,410
-5,779
| -41% | -$35.8K | ﹤0.01% | 5687 |
|
|
2022
Q4 | $90.5K | Buy |
14,189
+5,116
| +56% | +$32.6K | ﹤0.01% | 5507 |
|
|
2022
Q3 | $78K | Sell |
9,073
-2,163
| -19% | -$18.6K | ﹤0.01% | 5634 |
|
|
2022
Q2 | $153K | Sell |
11,236
-3,792
| -25% | -$51.6K | ﹤0.01% | 5499 |
|
|
2022
Q1 | $229K | Sell |
15,028
-4,985
| -25% | -$76K | ﹤0.01% | 5638 |
|
|
2021
Q4 | $458K | Buy |
20,013
+8,033
| +67% | +$184K | ﹤0.01% | 5180 |
|
|
2021
Q3 | $167K | Sell |
11,980
-290
| -2% | -$4.04K | ﹤0.01% | 5577 |
|
|
2021
Q2 | $131K | Buy |
12,270
+6,861
| +127% | +$73.3K | ﹤0.01% | 5578 |
|
|
2021
Q1 | $71K | Buy |
5,409
+3,755
| +227% | +$49.3K | ﹤0.01% | 5831 |
|
|
2020
Q4 | $34K | Buy |
+1,654
| New | +$34K | ﹤0.01% | 5688 |
|